• Mutation; HGNC; HGNC:1455; CALR; Simple; p.Leu367Metfs*43 (c.1099_1159del61); Zygosity=Heterozygous (PubMed=25249012; PubMed=30115971).
  
• Mutation; HGNC; HGNC:7217; MPL; Simple; p.Ser505Asn (c.1514G>A); ClinVar=VCV000014163; Zygosity=Heterozygous (PubMed=30115971).
  
• Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Lys (c.181C>A); ClinVar=VCV000073058; Zygosity=Heterozygous (PubMed=30115971).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Cys135Tyr (c.404G>A); ClinVar=VCV000141762; Zygosity=Homozygous (PubMed=30115971).
  

PubMed=9406575; DOI=10.1016/S0165-4608(97)00017-4
Hitoshi Yoshida, Makoto Kondo, Takuji Ichihashi, Naoya Hashimoto, Johji Inazawa, Ryuzo Ohno, Tomoki Naoe;
A novel myeloid cell line, Marimo, derived from therapy-related acute myeloid leukemia during treatment of essential thrombocythemia: consistent chromosomal abnormalities and temporary C-MYC gene amplification.
Cancer Genet. Cytogenet. 100:21-24(1998)

DOI=10.1016/B978-0-12-221970-2.50457-5
Hans Gunther Drexler;
The leukemia-lymphoma cell line factsbook.
(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001)

PubMed=16408098; DOI=10.1038/sj.leu.2404081
Hilmar Quentmeier, Roderick A.F. MacLeod, Margarete Zaborski, Hans Gunther Drexler;
JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders.
Leukemia 20:471-476(2006)

PubMed=21552520; DOI=10.1371/journal.pone.0019169; PMCID=PMC3084268
Ting-Lei Gu, Julie Nardone, Yi Wang, Marc Loriaux, Judit Villen, Sean A. Beausoleil, Meghan Tucker, Jon M. Kornhauser, Jian-Min Ren, Joan MacNeill, Steven P. Gygi ...Show all 15 authors... , Brian Jay Druker, Michael Charles Heinrich, John Rush, Roberto D. Polakiewicz; Show fewer authors
Survey of activated FLT3 signaling in leukemia.
PLoS ONE 6:e19169.1-e19169.10(2011)

PubMed=25249012; DOI=10.1038/leu.2014.285; PMCID=PMC4320290
Karoline Kollmann, Jyoti Nangalia, Wolfgang Warsch, Hilmar Quentmeier, Anthony Bench, Elaine Boyd, Michelle Scott, Hans Gunther Drexler, Anthony R. Green;
MARIMO cells harbor a CALR mutation but are not dependent on JAK2/STAT5 signaling.
Leukemia 29:494-497(2015)

PubMed=30115971; DOI=10.1038/s41375-018-0234-6
Li-Juan Han, Julia Czech, Angela Maurer, Tim Henrik Brummendorf, Nicolas Chatain, Steffen Koschmieder;
Mutant NRAS Q61K is responsible for MAPK pathway activation in the MARIMO cell line and renders these cells independent of the CALR-MPL-JAK2-STAT5 pathway.
Leukemia 32:2087-2090(2018)